Does Anyone in America Really Use CEA? Examples from the Field

Peter J. Neumann

in Using Cost-Effectiveness Analysis to Improve Health Care

Published in print December 2004 | ISBN: 9780195171860
Published online September 2009 | e-ISBN: 9780199865345 | DOI:
Does Anyone in America Really Use CEA? Examples from the Field

Show Summary Details


The resistance to CEA highlighted in Chapters 3–6 suggests that the technique has had little impact. CEA might be characterized as an elegant but forbidden tool, beautifully made but outlawed as too dangerous. Still, the possibility remains that CEA actually enjoys considerable influence, not as an explicit instrument for prioritizing health services, but as a more subtle input into decision making. By the dawn of the 21st century, cost-effectiveness analysts had carved out a distinctive place in mainstream academic American medicine, even as the studies' impacts remained elusive. This chapter describes the possible influence of CEA generally and on major stakeholders, including Medicare, Medicaid, insurance companies, and pharmaceutical companies.

Keywords: health policy; influence of cost-effectiveness; formularies; coverage decisions; insurance companies; pharmaceutical companies

Chapter.  8679 words.  Illustrated.

Subjects: Public Health and Epidemiology

Full text: subscription required

How to subscribe Recommend to my Librarian

Buy this work at Oxford University Press »

Users without a subscription are not able to see the full content. Please, subscribe or login to access all content.